FDA report: Drug quality tops OPQ's list of product defects
Regulatory NewsKari Oakes
APIsAudit/inspectionBiologics/ biosimilars/ vaccinesChemistry, Manufacturing and Controls (CMC)North AmericaPharmaceuticalsProduct LifecycleQuality Assurance and ControlRegulatory Intelligence/Policy